Literature DB >> 10971660

Reversible cognitive decline accompanies migraine and cluster headaches.

J S Meyer1, J Thornby, K Crawford, G M Rauch.   

Abstract

Vascular headaches, including migraine, cluster, and migrainous transformation to chronic daily headaches, are disabling. During and shortly after headache intervals, difficulties are reported in concentration, comprehension, and communication, not accounted for by nausea, photophobia, or sonophobia. These interfere with interpersonal relations and performance at work with economic loss. The hypothesis tested and reported here is that cognitive impairments comprise an important part of vascular headache diatheses. One hundred ninety-six otherwise normative subjects suffering from migraine or cluster, but not tension-type, headaches (136 women, 63 men; mean age, 46 years) participated in an outpatient prospective trial. One hundred thirty-three patients had migraine without aura, 39 migraine with aura, 11 periodic cluster (by IHS criteria), and 13 had migrainous transformation into chronic daily headaches. Neuropsychological testing was compared with and without headaches, by combined Mini-Mental Status Examination (MMSE), Cognitive Capacity Screening Examination (CCSE), and Hamilton Depression Rating Scale (HDRS). During headache intervals, significant decline was measured in both CCSE and MMSE scores (P <. 001) without HDRS change in all types of vascular headache and independent of headache severity, which often improved, or associated physical symptoms. Cognitive decline was promptly relieved by serotonin agonists and sleep. Disorders of cerebral serotoninergic projection systems appear to cause these reversible cognitive impairments.

Entities:  

Mesh:

Year:  2000        PMID: 10971660     DOI: 10.1046/j.1526-4610.2000.040008638.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  23 in total

1.  The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review.

Authors:  Diana M Higgins; Aaron M Martin; Dewleen G Baker; Jennifer J Vasterling; Victoria Risbrough
Journal:  Clin J Pain       Date:  2018-03       Impact factor: 3.442

Review 2.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

Review 3.  Cognition and Cognitive Impairment in Migraine.

Authors:  Raquel Gil-Gouveia; Isabel Pavão Martins
Journal:  Curr Pain Headache Rep       Date:  2019-09-11

4.  Development of the Cogniphobia Scale for Headache Disorders (CS-HD): A pilot study.

Authors:  Elizabeth K Seng; Jaclyn E Klepper
Journal:  Psychol Assess       Date:  2017-01-26

Review 5.  Assessment of cognitive dysfunction during migraine attacks: a systematic review.

Authors:  Raquel Gil-Gouveia; António G Oliveira; Isabel Pavão Martins
Journal:  J Neurol       Date:  2014-12-27       Impact factor: 4.849

Review 6.  Cognitive processing in cluster headache.

Authors:  Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2005-04

7.  Structural brain changes in migraine.

Authors:  Inge H Palm-Meinders; Hille Koppen; Gisela M Terwindt; Lenore J Launer; Junya Konishi; Juliette M E Moonen; Jacobus T N Bakkers; Paul A M Hofman; Baldur van Lew; Huub A M Middelkoop; Mark A van Buchem; Michel D Ferrari; Mark C Kruit
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

Review 8.  Migraine and cognitive decline: a topical review.

Authors:  Pamela M Rist; Tobias Kurth
Journal:  Headache       Date:  2013-02-13       Impact factor: 5.887

9.  Cognitive functioning in adolescents with migraine.

Authors:  Melissa Andréia Costa-Silva; Ana Carolina de Almeida Prado; Leonardo Cruz de Souza; Rodrigo Santiago Gomez; Antônio Lúcio Teixeira
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

10.  Intrinsic brain network abnormalities in migraines without aura revealed in resting-state fMRI.

Authors:  Ting Xue; Kai Yuan; Ling Zhao; Dahua Yu; Limei Zhao; Tao Dong; Ping Cheng; Karen M von Deneen; Wei Qin; Jie Tian
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.